H2AJ and breast cancer: H2AFJ was reported to be over-expressed in some cancers [7,8,9,11], and interrogation of the Cancer Genome Atlas (TCGA) database showed that prostate and breast cancer expressed high levels of H2AFJ mRNA (Figure 4, left panel).